MATERIALS AND METHODS Toxoplasma antigens. Toxoplasma antigens were prepared either from mice infected with the RH strain of T. gondii (2) or from cultures of human larynx carcinoma cells infected with a strain of T. gondii isolated in The Netherlands, i.e., strain Deelen (16) . Control Knapen (9) and with the Deelen strain as described by Van Loon and van der Veen (16 by three laboratories (A, C, and D). In the fourth laboratory (B), an absorbance value just below the absorbance value of the reference serum sample was found. Three other serum samples were positive only in the antibody capture assay, by one or both laboratories (C and D). These three serum samples contained IgG antibodies to toxoplasma but were negative for IgM antibodies to the 6-kilodalton antigen in the immunoblotting assay. The correlation coefficients between the IgM ELISA results from the four laboratories are shown in Table 1 The correlation coefficients between the results obtained in the assays in the four laboratories are shown in Table 2 .
Highly significant positive correlations were obtained between the results in the indirect ELISA and the antibody capture assay (0.78 s, r < 0.98; P < 0.002; x2 test), both with the ELISAs developed in the laboratories and with the commercial ELISA.
In addition, results obtained in the indirect ELISAs and antibody capture ELISAs from the laboratories were compared with the results of the immunoblotting assay. Again, highly significant correlation coefficients were obtained, both between the indirect ELISA and the immunoblotting assay (0.85 s r s 0.95; P < 0.002; x2 test) and between the antibody capture ELISA and the immunoblotting assay (0.88 . r . 0.98; P < 0.002; x2 test). In capture assay in laboratory C. Similar results were obtained with the results from the other laboratories.
By using Spearman's rank correlation coefficient, a moderate correlation between absorbance value and ratio was obtained (r, = 0.68; P < 0.0001). Two serum samples were positive in the indirect ELISA and negative in the antibody capture assay. One of these samples was also weakly positive in the immunoblotting assay. The other sample was from a patient with a history of toxoplasmosis. The four samples that were positive in the antibody capture assay and negative in the indirect ELISA were all from patients with a less recent toxoplasma infection. Previous samples from these patients, taken sooner after the onset of clinical signs, were positive in both assays. Three of these four serum samples were positive in the immunoblotting assay. The other sample showed a nonspecific reaction pattern.
Time course of IgM antibodies in follow-up serum samples from patients with toxoplasmosis. The persistence of IgM antibodies to T. gondii in follow-up sera from eight patients with a well-known onset of clinical symptoms varied from 3 to 13 months or more. Table 3 shows the results of the longitudinal study for the presence of IgG and IgM antibodies to T. gondii in three patients. These results illustrate the different time courses of IgM antibodies to T. gondii in the patients. In some patients, antitoxoplasma IgM levels decreased rapidly to the threshold value within 3 to 4 months; in others, toxoplasma IgM levels remained high for more than a year after infection.
Comparison of indirect and antibody capture ELISAs for discrimination between early and late stages of toxoplasma infection. Of the 50 serum samples tested, 29 were obtained from the eight patients for whom the onset of clinical symptoms was well-known. Consecutive samples from these patients showed a fourfold or greater rise in IgG antitoxoplasma titer. To compare the ability of the indirect ELISA and the antibody capture ELISA to discriminate between serum samples obtained in an early or a late stage after infection, these 29 samples were divided into two groups: one group contained serum samples obtained within 3 months after onset of clinical symptoms, and the other group contained samples obtained in a late stage. In addition to being tested by the indirect ELISA and antibody capture ELISA, samples were also tested by the immunoblotting assay for the presence of IgM antibodies to T. gondii. Our results show that recognition of the 6-kilodalton band as described by Sharma et al. (12) was highly correlated with detection of IgM antitoxoplasma antibodies by indirect ELISA or antibody capture ELISA.
The time course of IgM antibodies to T. gondii varied considerably, independently of the test used. In some patients, IgM antibodies to T. gondii persisted for only 3 to 4 months; in other patients, the antibodies persisted for more than a year. This finding has also been reported by other investigators (7, 8, 15) . Either system was able to demonstrate the presence of IgM antibodies to toxoplasma for more than a year.
As stated by Siegel and Remington (13), the indirect ELISA measures an absolute concentration of IgM antitoxoplasma antibodies, whereas the antibody capture ELISA measures the immune load. They also reported that the immune load of toxoplasma IgM antibody as measured by the antibody capture assay discriminates better between serum samples obtained at early and late stages after toxoplasma infection than does the absolute concentration of IgM antitoxoplasma antibodies. The results obtained in our study for 29 serum samples from eight clinically well-defined patients are in agreement with those of Siegel and Remington (13) .
In conclusion, the results presented in this study show that the indirect ELISA and the antibody capture ELISA had equal sensitivity in detecting IgM antibodies to toxoplasma early after infection, whereas the IgM immunoblotting assay seems useful as a confirmation assay. The antibody capture assay discriminated better between serum samples obtained in the early and late stages of toxoplasma infection.
